C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/2001
12/20/2001	WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents
12/20/2001	WO1999019304A3 Alpha-alkylthio substituted pyrimidine ethers and thioethers as viral reverse transcriptase inhibitors
12/20/2001	US20010053785 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
12/20/2001	DE10029285A1 New 3-(anilino-methylidene)-2-indolinone derivatives, are kinase inhibitors and cell proliferation inhibitors, useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis
12/20/2001	CA2412632A1 Hmg-coa reductase inhibitors and method
12/20/2001	CA2412353A1 Protease inhibitors
12/19/2001	EP1164136A1 Long wavelength absorbing bacteriochlorin alkyl ether analogs
12/19/2001	EP1163240A1 Tricyclic benzoylpyrazole derivatives used as a herbicide
12/18/2001	US6331638 Process for the preparation of 1,8-disubstituted-1,3,4,9-tetrahydropyrano (3,4-B)-indole-1-acetic acid esters
12/18/2001	US6331630 Dimeric arylisoquinoline alkaloids and derivatives thereof
12/13/2001	WO2001049275A3 Methods and compositions for mitigating pain using nitrate esters
12/13/2001	WO2001025241A3 Fused 1-(2,6-dichloro-4-trifluoromethylphenyl)-pyrazoles, the synthesis thereof and the use thereof as pesticides
12/13/2001	US20010051724 Introducing chirality at position 20 as penultimate step reduces waste, cost of materials handling and risk of contamination; chemical intermediates
12/13/2001	US20010051722 Aminoaryl Oxazolidinone N-oxides
12/13/2001	US20010051651 Administering effective amount of 1,3,6-trihydro-6-aza-3-oxapentalen-2-one derivative to the patient for inducing or promoting apoptosis and for arresting uncontrolled neoplastic cell proliferation
12/13/2001	US20010051633 E.g.,N-((4-amino-3-nitrophenoxy)ethyl)-1,2,3,4-tetrahydro -isoquinoline; stroke; antiischemic agents; CNS trauma, hyperglycemic agents; surgery; neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis
12/13/2001	US20010051620 Tricyclic protein kinase inhibitors
12/12/2001	EP1161434A1 Pyridopyranoazepine derivatives, preparation and therapeutic use
12/12/2001	EP0934329B1 Glycoconjugates from modified camptothecin derivates (20-o-linkage)
12/12/2001	CN1326351A Use of certain drugs for treating nerve root injury
12/11/2001	US6329525 High affinity for mitochondrial diazepam binding inhibitor receptor (mdr); anxiolytic agents, side effect reduction
12/11/2001	US6329387 Use of thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
12/11/2001	US6329385 Antiinflammatory agents, antiarthritic agents, viral diseases and gastrointestinal disorders
12/11/2001	US6329364 Crystalline form of dihydro-2,3-benzodiazepine derivative
12/06/2001	WO2001092265A2 Indolinospiropyran compounds and methods for their manufacture
12/06/2001	WO2001092255A2 Epothilone derivatives and methods for making and using the same
12/06/2001	WO2001092226A1 Heterocyclic analgesic compounds and method of use thereof
12/06/2001	US20010049379 Nitric oxide synthase inhibitors; treatment and prevention of central nervous system and other disorders.
12/06/2001	US20010049377 Glucocortiocoid-selective antiinflammatory agents
12/06/2001	US20010049371 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases
12/06/2001	DE10012825A1 Verfahren zur Herstellung von spirocyclischen Tetronsäurederivaten Process for the preparation of spirocyclic Tetronsäurederivaten
12/05/2001	EP1158986A1 Protease inhibitors
12/05/2001	EP0845988B1 Novel fused isoquinolines as dopamine receptor ligands
12/05/2001	EP0548103B1 Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria
12/05/2001	CN1325399A Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists
12/05/2001	CN1325390A 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/05/2001	CN1325380A Benzene derivatives and medical use thereof
12/05/2001	CN1325305A Method of administering camptothecin compounds for the treatment of cancer with reduced side effects
12/05/2001	CN1075799C Monomers and composition which can be crosslinked and crosslinked polymers
12/04/2001	US6326380 Thrombin receptor antagonists
12/04/2001	US6326377 Psychological disorders therapy
12/04/2001	US6326375 Containing an urea group
12/04/2001	US6326153 Polynucleotide sequencing
11/2001
11/29/2001	WO2001090253A1 Stable near-infrared (nir) marker dyes based on benzopyrylium-polymethines
11/29/2001	WO2001090113A1 Hydroxylamine esters as polymerization initiators
11/29/2001	WO2001090094A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090093A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090092A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090091A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090090A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090084A1 Benzodiazepine derivatives as app modulators
11/29/2001	WO2001089526A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/29/2001	WO2001089451A2 Protease inhibitors
11/29/2001	US20010047026 Treatment of disorders associated with smooth muscle contraction such as incontinence and irritable bowel syndrome
11/29/2001	US20010047007 Tyrosine kinase inhibitors
11/29/2001	DE10025728A1 Neue Carbamate und Harnstoffe, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten New carbamates and ureas, their preparation and use as endothelin receptor antagonists
11/29/2001	CA2409998A1 Benzodiazepine derivatives as app modulators
11/29/2001	CA2408791A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/29/2001	CA2408783A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	CA2406829A1 Protease inhibitors
11/28/2001	EP1157992A1 Dihydro-2,3-Benzodiazepine derivatives
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP1156808A2 Enhancement of return to independent living status with a growth hormone secretagogue
11/28/2001	EP0911336B1 Pyridonecarboxylic acid derivatives and intermediates for the synthesis thereof
11/28/2001	CN1075503C Production method for camptothecine
11/28/2001	CN1075502C Process for preparing camptothecine
11/28/2001	CN1075501C Camptothecin derivatives, prepn. method, intermediate and uses
11/28/2001	CN1075500C Process of prepn. novel coumaric quinolone carboxylic acid and uses thereof
11/27/2001	US6323217 Cardiovascular disorders
11/27/2001	US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines
11/27/2001	US6323197 Non-competitive inhibiting of the ampa receptors, these compounds can be used as medicaments for treatment of the central nervous system
11/27/2001	US6323196 Galanthamine derivatives as acetylcholinesterase inhibitors
11/27/2001	US6323195 Enzyme inhibitors and cognition activators
11/27/2001	CA2214037C Method of making camptothecin and camptothecin analogs
11/27/2001	CA2073446C Pyridylsulfonylureas as herbicides and plant growth regulators, processes for their preparation and their use
11/22/2001	WO2001087895A1 Synthetic process for the manufacture of an ecteinaschidin compound
11/22/2001	WO2001087894A1 Antitumoral analogs of et-743
11/22/2001	WO2001087892A1 Crf receptor antagonists
11/22/2001	WO2001087883A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
11/22/2001	WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	WO2001087846A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
11/22/2001	WO2001087845A2 N-containing heterocyclic compounds and their use as 5-ht antagonists
11/22/2001	WO2001087844A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
11/22/2001	WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001	WO2001087304A1 Ophthalmic solution
11/22/2001	WO2001087303A1 Aqueous liquid preparation
11/22/2001	WO2001087038A2 β-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE
11/22/2001	WO2001025239A3 Oxazinoquinolones useful for the treatment of viral infections
11/22/2001	WO2001012607B1 Pharmaceutical compositions comprising 4-quinolones for treating cancers
11/22/2001	US20010044538 Mitogen-activated protein (MAP) kinase; treating inflammatory diseases; compounds such as 3-(4-fluorophenyl)-1-hydroxy-2-(pyridin-4-yl)-1H-pyrrolo(3,2-b)pyridine
11/22/2001	US20010044435 Antitumor agents, treatment of the lungs and respiratory tract
11/22/2001	CA2410077A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	CA2409225A1 Tricyclic pyrazole derivatives
11/22/2001	CA2408849A1 Cyclohexane derivatives and their use as therapeutic agents
11/21/2001	EP1156050A2 Substituted tricyclics useful in sPLA2 induced diseases
11/21/2001	EP1156045A1 Amide derivatives and drug compositions
11/21/2001	EP1155020A2 Furo[3,2-b]pyridines as 5-ht1f agonists
11/21/2001	EP1154997A1 Pharmaceutically active compounds and methods of use thereof
11/21/2001	EP0918774B1 Androgen receptor modulator compounds and methods
11/21/2001	EP0745081B1 indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase

1 ... 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 ... 298